Shattuck Labs, Inc. Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation
Shattuck Labs, Inc. (STTK) reported Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation of 1.07 thousand shares for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation · last filed 2024-05-02
- Shattuck Labs, Inc. share-based payment arrangement, shares withheld for tax withholding obligation for the quarter ending 2023-09-30 was 1.07K shares.
- Shattuck Labs, Inc. share-based payment arrangement, shares withheld for tax withholding obligation for the quarter ending 2023-03-31 was 16.15K shares.
| Period end | Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation 3 month |
|---|---|
| 2023-09-30 | 1.07K shares 10-Q · filed 2023-11-09 |
| 2023-03-31 | 16.15K shares 10-Q · filed 2024-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |